Our FDA-cleared DL Precise automates lesion segmentation and measurement with unprecedented precision in multiple imaging modalities – all with a single click. From initial screening and diagnosis through treatment, recovery and monitoring, its one-click consistency and vivid display of tumor morphology help ensure the highest standard of care.

Leveraging our patented shape-recognition software, we’re partnering with innovators who are:

•  using the latest in image display technology (Barco)
• integrating platforms that offer the best of AI (Arterys)
• introducing flexible viewers that leverage the potential of Cloud-based imaging (Radical Imaging)